ALS-linked mutations in SPTLC1 cause altered substrate specificity and/or unrestrained activity of SPT (a key enzyme in ceramide synthesis), leading to accumulation of 1-deoxysphingolipids [142] or ceramides [17]. The gene discussed is SPTLC1; the disease is amyotrophic lateral sclerosis.